BioMark Diagnostics Inc.
BUX
Rank in Stocks
#26607
BioMark Diagnostics Inc. is an oncology specialist, developing advanced... BioMark Diagnostics Inc. is an oncology specialist, developing advanced diagnostic tools for cancer to enable early detection, continuous patient monitoring, and the assessment of initial treatment efficacy. The firm holds a research partnership with the Icahn School of Medicine, collaborating on clinical trials specifically addressing the early identification of lung cancer. Founded in 2014, its corporate headquarters are situated in Richmond, Canada. BioMark Diagnostics Inc. operates as a subsidiary of Biomark Technologies Inc.
Share Price
$0.34495034
Last synced: 2026-10-16
Market Cap
$36.73M
Change (1 day)
-4.08%
Change (1 year)
41.11%
Country
CA
Trade BioMark Diagnostics Inc. (BUX)
Category
Healthcare
Stock split history for BioMark Diagnostics Inc. (BUX)
BioMark Diagnostics Inc. stock (symbol: BUX) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One BUX share bought prior to Oct 20, 2026 would equal to 0 BUX shares today.
The most recent stock split occurred on Oct 20, 2026.
One BUX share bought prior to Oct 20, 2026 would equal to 0 BUX shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 8 | x34 |
US
|
|
| 7 | x47 |
US
|
|
| 0 | - |
US
|
|
| 0 | - |
CN
|
|
| 1 | x1 |
US
|
